Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

SCC257 OVCAR-3 Human Ovarian Cancer Cell Line

OVCAR-3 cell line is a well-established model system for ovarian carcinoma.

SCC257
≥1X10⁶ cells/vial   
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberSCC257
DescriptionOVCAR-3 Human Ovarian Cancer Cell Line
Alternate Names
  • OVCAR3
Background InformationOvarian carcinoma is a prevalent worldwide disease, with over 200,000 new cases diagnosed per year (1). The first-line chemotherapy for newly-diagnosed ovarian carcinoma is cisplatin, but despite high initial efficacy, the most common types of ovarian carcinomas frequently relapse into platinum-resistant forms and many demonstrate multi-drug resistance (1). The availability of cellular models that recapitulate both resistant and susceptible forms of the disease are essential to understanding drug resistance and advancing new options for treatment.

OVCAR-3 is a high-grade serous ovarian adenocarcinoma cell line established from a patient refractory to cisplatin, however the cell line remains sensitive to a variety of chemotherapeutic drugs (2). OVCAR-3 cells demonstrate increased glutathione content (3) and express the Wilms Tumor 1 protein (WT1), a marker of advanced serous ovarian carcinoma (4). OVCAR-3 cells are characterized by migration/invasion ability and are tumorigenic in nude mice (5). The OVCAR-3 cell line is well-established and one of the most highly-cited model systems for ovarian carcinoma.

Source:
OVCAR-3 was established from ascitic fluid from a 60-year-old patient with ovarian cancer refractory to cisplatin treatment (2).

References:
1. Nat Rev Disease Primers 2016; 2:16061.
2. Cancer Res 1997; 57:850—856.
3. Proc Natl Acad Sci USA 1992; 89:3070-3074.
4. BMC Cancer 2006; 6:90.
5. Gynecol Oncol 2015;138(2):372-377.
References
Product Information
Applications
ApplicationOVCAR-3 cell line is a well-established model system for ovarian carcinoma.
Key Applications
  • Cell Culture
Application NotesThis product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
Biological Information
Cell Line Type
  • Cancer Cells
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality Assurance• Each vial contains ≥ 1X10⁶ viable cells.
• Cells are tested negative for infectious diseases by a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.
• Cells are verified to be of human origin and negative for inter-species contamination from rat, mouse, chinese hamster, Golden Syrian hamster, and non-human primate (NHP) as assessed by a Contamination CLEAR panel by Charles River Animal Diagnostic Services.
• Cells are negative for mycoplasma contamination.
• Each lot of cells is genotyped by STR analysis to verify the unique identity of the cell line.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStore in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
Packaging Information
Material Size≥1X10⁶ cells/vial
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
SCC257 04061842403479